Intelligent Bio Solutions (INBS) Assets Average (2021 - 2024)
Intelligent Bio Solutions has reported Assets Average over the past 4 years, most recently at $12.9 million for Q1 2024.
- Quarterly results put Assets Average at $12.9 million for Q1 2024, down 9.93% from a year ago — trailing twelve months through Mar 2024 was $12.9 million (down 9.93% YoY), and the annual figure for FY2023 was $11.4 million, down 33.63%.
- Assets Average for Q1 2024 was $12.9 million at Intelligent Bio Solutions, up from $8.8 million in the prior quarter.
- Over the last five years, Assets Average for INBS hit a ceiling of $20.5 million in Q3 2021 and a floor of $8.8 million in Q4 2023.
- Median Assets Average over the past 4 years was $14.1 million (2022), compared with a mean of $14.3 million.
- Biggest five-year swings in Assets Average: plummeted 45.05% in 2022 and later decreased 2.97% in 2023.
- Intelligent Bio Solutions' Assets Average stood at $17.2 million in 2021, then dropped by 17.87% to $14.1 million in 2022, then plummeted by 37.86% to $8.8 million in 2023, then skyrocketed by 47.57% to $12.9 million in 2024.
- The last three reported values for Assets Average were $12.9 million (Q1 2024), $8.8 million (Q4 2023), and $9.5 million (Q3 2023) per Business Quant data.